カリブー・バイオサイエンシズに関するコメント

$カリブー・バイオサイエンシズ(CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud

$カリブー・バイオサイエンシズ(CRBU.US)$ Caribou Biosciences Expands Clinical Development Of CB-010 With FDA Clearance Of IND In Lupus
Benzinga· 4 mins ago
- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 --
-- Driven by encouraging initial safety and efficacy in the ongoing ANTLER trial for r/r B-NHL, CB-010 clinical development has expanded to include autoimmune diseases --
-- Advancing ANT...

$カリブー・バイオサイエンシズ(CRBU.US)$  this stock 🥲

$カリブー・バイオサイエンシズ(CRBU.US)$ Caribou Biosciences (CRBU) said late Tuesday it has reached alignment with the US Food and Drug Administration with respect to the trial design of a planned phase 3 study of CB-010 for the treatment of patients with second-line relapsed or refractory large B cell lymphoma.
The regulator found a proposed comparator arm of platinum-based immunochemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation to be "acceptable," the compan...

$カリブー・バイオサイエンシズ(CRBU.US)$ Bring on the volume! Another PR just hitting most outlets now! Hehehe

$カリブー・バイオサイエンシズ(CRBU.US)$ Caribou Biosciences, Inc. Awarded FDA Orphan Designation Status For Allogeneic CAR-T Cells That Is Engineered To Express A Car Targeting The B Cell Maturation Antigen For The Treatment Of Multiple Myeloma

$カリブー・バイオサイエンシズ(CRBU.US)$
collecting cheap price